ப்ராஜெக்ட் ஓனிக்ஸ் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ப்ராஜெக்ட் ஓனிக்ஸ். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ப்ராஜெக்ட் ஓனிக்ஸ் Today - Breaking & Trending Today

Overnight Health Care: FDA adds new warning to J&J COVID-19 vaccine | WHO chief pushes back on Pfizer booster shot | Fauci defends Biden's support for recommending vaccines 'one on one'


ADVERTISEMENT
Today: The FDA is adding a warning to Johnson & Johnson s COVID-19 vaccine, the WHO is pushing back on Pfizer s calls for a booster dose, and a House panel wants information from Biogen about its controversial Alzheimer s drug.
We’ll start with J&J:
FDA adds new warning to J&J COVID-19 vaccine
The Food and Drug Administration (FDA) is adding a label to Johnson & Johnson s COVID-19 vaccine, warning that it has been linked to rare cases of Guillain-Barré syndrome (GBS), a neurological disorder in which the body s immune system mistakenly attacks part of its nervous system.
There have been 100 preliminary reports following vaccination after approximately 12.5 million doses administered, FDA said in a statement. Of these reports, 95 of them were serious and required hospitalization. There was one reported death. ....

United States , New York , White House , District Of Columbia , Rosa Delauro , Carolyn Maloney , Janet Woodcock , Tedros Adhanom Ghebreyesus , Mike Ryan , Tom Cole , Frank Pallone Jr , Jen Psaki , Welcome To Monday Overnight Health Care , Appropriations Committee , United States Senate , Africa Vaccine Acquisition Task Team , Kaiser Health News , Department Of Health , Human Services , Kansas News Service , Drug Administration , Commerce Committee , World Health Organization , House Energy , House Oversight Committee , New York Times ,

Democrats demand docs about Biogen, FDA coordination on Aduhelm


advertisement
Acting FDA Commissioner Janet Woodcock on Friday called for an independent watchdog to investigate whether any interactions between FDA staff and Biogen violated FDA policies.
The committee is also seeking documents related to Biogen’s role in an FDA move last week to narrow prescribing guidelines to patients with the earliest stages of Alzheimer’s, as opposed to any patient with the disease. STAT reported that even some senior FDA officials were surprised by the decision for such a wide initial label, and a source close to Biogen told STAT that the company wanted a narrower label “from the start, but was reluctant to push back on FDA’s desire for a broader label for fear it could derail approval.” ....

United States , Carolyn Maloney , Michel Vounatsos , Frank Pallone , House Committee On Oversight , House Democrats , House Committee , Reform Chair Carolyn Maloney , Commerce Chair Frank Pallone , Project Onyx , Janet Woodcock , ஒன்றுபட்டது மாநிலங்களில் , கரோலின் மலோநீ , வெளிப்படையான பல்ளோனே , வீடு குழு ஆன் ஓவர்‌ஸைட் , வீடு ஜனநாயகவாதிகள் , வீடு குழு , சீர்திருத்தம் நாற்காலி கரோலின் மலோநீ , வர்த்தகம் நாற்காலி வெளிப்படையான பல்ளோனே , ப்ராஜெக்ட் ஓனிக்ஸ் , ஜேனட் மரக்கட்டை ,